肿瘤药-话题@MedSci

#肿瘤药#

125篇内容 | 3264人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1537751, encodeId=40c7153e75101, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则（2020年版），覆盖9大癌肿、83种药物, objectType=article, longId=205369, objectId=79a62053694e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a62053694e, replyNumber=0, likeNumber=89, createdTime=2021-01-07, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a62053694e, moduleTitle=新型抗肿瘤药物临床应用指导原则（2020年版），覆盖9大癌肿、83种药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79a62053694e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537750, encodeId=58bf153e75048, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=国家卫健委发布《抗肿瘤药物临床应用管理办法(试行)》, objectType=article, longId=205022, objectId=d2112050227c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2112050227c, replyNumber=0, likeNumber=67, createdTime=2021-01-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2112050227c, moduleTitle=国家卫健委发布《抗肿瘤药物临床应用管理办法(试行)》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2112050227c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537749, encodeId=6af5153e749bc, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=【深度盘点】2020年FDA批准53款新药上市，肿瘤药占1/3, objectType=article, longId=204937, objectId=1aee20493e5e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aee20493e5e, replyNumber=0, likeNumber=84, createdTime=2020-12-29, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aee20493e5e, moduleTitle=【深度盘点】2020年FDA批准53款新药上市，肿瘤药占1/3, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aee20493e5e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537748, encodeId=3f8b153e7482f, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Science Advances ：重大进展！上海科技大学余鹰等首次建立抗肿瘤药引起的心血管风险的遗传证据, objectType=article, longId=202419, objectId=da222024192c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da222024192c, replyNumber=0, likeNumber=116, createdTime=2020-10-25, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da222024192c, moduleTitle=Science Advances ：重大进展！上海科技大学余鹰等首次建立抗肿瘤药引起的心血管风险的遗传证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da222024192c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537747, encodeId=89f4153e74796, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系, objectType=article, longId=197888, objectId=11e419e88810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e419e88810, replyNumber=0, likeNumber=78, createdTime=2020-07-23, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e419e88810, moduleTitle=专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e419e88810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537746, encodeId=34c0153e7464d, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知, objectType=article, longId=197705, objectId=a79a19e70511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a79a19e70511, replyNumber=0, likeNumber=70, createdTime=2020-07-19, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a79a19e70511, moduleTitle=关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a79a19e70511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537745, encodeId=8534153e74525, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=罗氏制药助力消化道肿瘤药物创新，面向中国征集合作伙伴，将提供资金、药物及研发支持, objectType=article, longId=197184, objectId=a46119e1844f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a46119e1844f, replyNumber=0, likeNumber=86, createdTime=2020-07-09, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a46119e1844f, moduleTitle=罗氏制药助力消化道肿瘤药物创新，面向中国征集合作伙伴，将提供资金、药物及研发支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a46119e1844f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537744, encodeId=e23e153e74456, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验, objectType=article, longId=196559, objectId=e8de1965590d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8de1965590d, replyNumber=0, likeNumber=67, createdTime=2020-06-28, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8de1965590d, moduleTitle=FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8de1965590d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537743, encodeId=86af153e743ab, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验, objectType=article, longId=196558, objectId=65c9196558ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65c9196558ff, replyNumber=0, likeNumber=79, createdTime=2020-06-28, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65c9196558ff, moduleTitle=FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65c9196558ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537742, encodeId=13df153e742b4, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, objectType=article, longId=193976, objectId=40ab1939e692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ab1939e692, replyNumber=0, likeNumber=100, createdTime=2020-05-13, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ab1939e692, moduleTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ab1939e692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537741, encodeId=0775153e741ec, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, objectType=article, longId=191066, objectId=430b191066c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430b191066c8, replyNumber=0, likeNumber=60, createdTime=2020-03-31, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430b191066c8, moduleTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=430b191066c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537740, encodeId=0e39153e740e6, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药物临床试验的特点和医学伦理问题, objectType=article, longId=191059, objectId=d683191059eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d683191059eb, replyNumber=0, likeNumber=98, createdTime=2020-03-31, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d683191059eb, moduleTitle=抗肿瘤药物临床试验的特点和医学伦理问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d683191059eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537739, encodeId=e91c153e739f2, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, objectType=article, longId=190197, objectId=f41f19019e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41f19019e2a, replyNumber=0, likeNumber=62, createdTime=2020-03-19, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41f19019e2a, moduleTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41f19019e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537738, encodeId=05ec153e738a3, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则（2019版）, objectType=article, longId=190150, objectId=bc2f190150bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc2f190150bd, replyNumber=0, likeNumber=86, createdTime=2020-03-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc2f190150bd, moduleTitle=新型抗肿瘤药物临床应用指导原则（2019版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc2f190150bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537737, encodeId=7f01153e73732, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药临床试验的统计设计分析, objectType=article, longId=190119, objectId=641e19011966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=641e19011966, replyNumber=0, likeNumber=107, createdTime=2020-03-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=641e19011966, moduleTitle=抗肿瘤药临床试验的统计设计分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=641e19011966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537736, encodeId=2996153e73665, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, objectType=article, longId=189805, objectId=e2d418980531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2d418980531, replyNumber=0, likeNumber=70, createdTime=2020-03-13, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2d418980531, moduleTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2d418980531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537735, encodeId=6961153e73518, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=2019 年 FDA 批准上市的抗肿瘤药, objectType=article, longId=185751, objectId=4ed9185e5175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ed9185e5175, replyNumber=0, likeNumber=65, createdTime=2020-01-07, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ed9185e5175, moduleTitle=2019 年 FDA 批准上市的抗肿瘤药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ed9185e5175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537734, encodeId=78ce153e734e8, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则（2019年版）, objectType=article, longId=185023, objectId=53921850232f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53921850232f, replyNumber=0, likeNumber=86, createdTime=2019-12-22, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53921850232f, moduleTitle=新型抗肿瘤药物临床应用指导原则（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53921850232f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537733, encodeId=9875153e733ad, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布, objectType=article, longId=184820, objectId=1fe71848207f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe71848207f, replyNumber=0, likeNumber=70, createdTime=2019-12-17, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe71848207f, moduleTitle=可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe71848207f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537732, encodeId=41ce153e732dc, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=肿瘤药物治疗相关恶心呕吐防治中国专家共识（2019年版）, objectType=article, longId=183779, objectId=d797183e7908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d797183e7908, replyNumber=0, likeNumber=43, createdTime=2019-11-30, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d797183e7908, moduleTitle=肿瘤药物治疗相关恶心呕吐防治中国专家共识（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d797183e7908)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤药

2020-05-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

新型抗肿瘤药物临床应用指导原则（2020年版），覆盖9大癌肿、83种药物

2021-01-07

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

国家卫健委发布《抗肿瘤药物临床应用管理办法(试行)》

2021-01-01

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

【深度盘点】2020年FDA批准53款新药上市，肿瘤药占1/3

2020-12-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Science Advances ：重大进展！上海科技大学余鹰等首次建立抗肿瘤药引起的心血管风险的遗传证据

2020-10-25

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

专家呼吁关注抗肿瘤药全生命周期管理建立和完善质量管理体系

2020-07-23

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知

2020-07-19

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

罗氏制药助力消化道肿瘤药物创新，面向中国征集合作伙伴，将提供资金、药物及研发支持

2020-07-09

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

FDA批准抗肿瘤药物PI3Kα抑制剂CYH33临床试验

2020-06-28

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

FDA批准抗肿瘤药物IDH1抑制剂HH2301临床试验

2020-06-28

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发

2020-05-13

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药物临床试验中风险评估与应对措施的探讨

2020-03-31

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药物临床试验的特点和医学伦理问题

2020-03-31

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗

2020-03-19

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

新型抗肿瘤药物临床应用指导原则（2019版）

2020-03-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药临床试验的统计设计分析

2020-03-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用

2020-03-13

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

2019 年 FDA 批准上市的抗肿瘤药

2020-01-07

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

新型抗肿瘤药物临床应用指导原则（2019年版）

2019-12-22

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

可及性实用性兼具升级版《消化系统抗肿瘤药物合理用药指南》在京发布

2019-12-17

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

肿瘤药物治疗相关恶心呕吐防治中国专家共识（2019年版）

2019-11-30

科室
- - 订阅+
  - 更多科室
工具
服务